News
During a panel, Walensky and Chip Kahn, CEO of Federation of American Hospitals, discussed current policies they say are negatively impacting the healthcare sector.
The multi-task model, trained on 80,000 patient records, predicts three key postoperative risks and validates consistently across several hospitals.
The model also calculates biological ageing and survival patterns to support personalized health risk management.
OpenEvidence will integrate content from the NCCN guidelines in oncology into its clinician-facing AI platform.
Daryl Tol, president of General Catalyst’s Health Assurance Transformation Company (HATCo), shares an update on the current state of the venture firm’s healthcare system.
Also, South Korea has piloted a social media app-based counselling service for reclusive teens.
TrumpRx will offer Novo Nordisk's Ozempic and Wegovy for $350 and Eli Lilly and Company's Zepbound and orforglipron, if approved by the FDA, for $346.
The funds will be used to further invest in its product innovation, including its Polaris Safety Constellation Architecture, and to merge with or purchase other companies.
The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials and commercialization of its BCI.
At Future of Health’s invitation-only event, former CDC Director Dr. Rochelle Walensky sat down with MobiHealthNews to discuss the potential and challenges of AI in healthcare.